Oppenheimer analyst Suraj Kalia reiterated a Perform rating on Procept BioRobotics Corp (NASDAQ: PRCT).The analyst comments "The Aquablation procedure vs ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE